Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
By C. Kuhl, S. Schrading, C. Leutner, N. Morakkabati-Spitz, E. Wardelmann, R. Fimmers, W. Kuhn, H. Schild. Journal of Clinical Oncology, 2005
1,170 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/d945d7062a8b20aef95a84c8ff4ff7287cd22007
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. (2008, neutral): “Age at enrollment, yb Median (range) 55 (25-91) 55 (25-91)”
- Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. (2010, background): “strated superior sensitivity of MRI for cancer detection in high-risk women [61,63,80].”
- Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. (2010, background): “75 However, the absence of randomisation in these studies introduced significant bias because of the inclusion of smaller and less aggressive tumours in the group who underwent MRI.”
- Detection of Breast Cancer with Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women with Elevated Breast Cancer Risk (2012, neutral): “DCIS, nuclear grade 15 (45) 3 (12) 2 (6) 1 (9) 1 (11) 22 (20)”